MINNELIDE, A PROMISING COMPOUND FOR THE TREATMENT OF HIGH-RISK MEDULLOBLASTOMA

被引：0
|
作者：
Blanco, Jezabel Rodriguez [1 ]
Salvador, April [1 ]
Sahani, Pritika [1 ]
Kliebe, Valentin [1 ]
Peterson, Kendell [1 ]
Turos, Maria [1 ]
机构：
[1] Med Univ South Carolina, Charleston, SC USA
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae064.555
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MDB-107
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical models
    Rodriguez-Blanco, Jezabel
    Salvador, April D.
    Suter, Robert K.
    Swiderska-Syn, Marzena
    Palomo-Caturla, Isabel
    Kliebe, Valentin
    Shahani, Pritika
    Peterson, Kendell
    Turos-Cabal, Maria
    Vieira, Megan E.
    Wynn, Daniel T.
    Howell, Ashley J.
    Yang, Fan
    Ban, Yuguang
    McCrea, Heather J.
    Zindy, Frederique
    Danis, Etienne
    Vibhakar, Rajeev
    Jermakowicz, Anna
    Martin, Vanesa
    Coss, Christopher C.
    Harris, Brent T.
    de Cubas, Aguirre
    Chen, X. Steven
    Barnoud, Thibaut
    Roussel, Martine F.
    Ayad, Nagi G.
    Robbins, David J.
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (15):
  • [2] Temozolomide in the management of high-risk medulloblastoma/PNET:: A promising pilot experience
    Fruehwald, M. C.
    Juergens, H.
    Paulus, W.
    Straeter, R.
    NEURO-ONCOLOGY, 2007, 9 (02) : 190 - 190
  • [3] NEUROIMAGING AND THE OUTCOME OF TREATMENT OF HIGH-RISK MEDULLOBLASTOMA PATIENTS
    NIGRO, MA
    KURDONOWICZ, B
    MOSIJCZUK, AD
    MULNE, AF
    ANNALS OF NEUROLOGY, 1990, 28 (03) : 417 - 417
  • [4] Management of high-risk medulloblastoma
    Bouffet, E.
    NEUROCHIRURGIE, 2021, 67 (01) : 61 - 68
  • [5] Preclinical Modeling of Clinically Relevant Radiation Therapy for Treatment of High-Risk Medulloblastoma
    Smith, S. M. C.
    Tinkle, C. L.
    Bianski, B. M.
    Orr, B. A.
    Robinson, G. W.
    Morel, V.
    Gilbertson, R. J.
    Gajjar, A.
    Merchant, T. E.
    Roussel, M. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S147 - S147
  • [6] TREATMENT OF HIGH-RISK MEDULLOBLASTOMA AND PRIMITIVE NEUROECTODERMAL TUMORS WITH PREIRRADIATION CISPLATIN AND ETOPOSIDE
    KOVNAR, E
    KUN, L
    HOROWITZ, M
    ETCUBANAS, E
    DOUGLASS, E
    MULHERN, R
    SANFORD, R
    LANGSTON, J
    ANNALS OF NEUROLOGY, 1988, 24 (02) : 361 - 362
  • [7] A promising step for high-risk FL
    Huebel, Kai
    BLOOD, 2024, 143 (17) : 1679 - 1681
  • [8] Promising new treatment shows potential for high-risk bladder cancer
    Nierengarten, Mary Beth
    CANCER, 2024, 130 (18)
  • [9] High-risk Medulloblastoma-Balancing the High Stakes of Molecular Profiling to Enhance Treatment Responsivity
    Martin, Allison M.
    Jackson, Sadhana
    JAMA ONCOLOGY, 2021, 7 (09) : 1322 - 1323
  • [10] CHEK2 MUTATION IN HIGH-RISK MEDULLOBLASTOMA
    Shah, Nidhi
    Walter, Andrew
    NEURO-ONCOLOGY, 2018, 20 : 170 - 171
12345